These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 30220444)
1. National registry of patients with Fukuyama congenital muscular dystrophy in Japan. Ishigaki K; Ihara C; Nakamura H; Mori-Yoshimura M; Maruo K; Taniguchi-Ikeda M; Kimura E; Murakami T; Sato T; Toda T; Kaiya H; Osawa M Neuromuscul Disord; 2018 Oct; 28(10):885-893. PubMed ID: 30220444 [TBL] [Abstract][Full Text] [Related]
2. Founder mutation causes classical Fukuyama congenital muscular dystrophy (FCMD) in Chinese patients. Yang H; Kobayashi K; Wang S; Jiao H; Xiao J; Toda T; Wu X; Xiong H Brain Dev; 2015 Oct; 37(9):880-6. PubMed ID: 25814170 [TBL] [Abstract][Full Text] [Related]
3. Deep-intronic variant of fukutin is the most prevalent point mutation of Fukuyama congenital muscular dystrophy in Japan. Kobayashi K; Kato R; Kondo-Iida E; Taniguchi-Ikeda M; Osawa M; Saito K; Toda T J Hum Genet; 2017 Nov; 62(11):945-948. PubMed ID: 28680109 [TBL] [Abstract][Full Text] [Related]
4. Respiratory management of patients with Fukuyama congenital muscular dystrophy. Sato T; Murakami T; Ishiguro K; Shichiji M; Saito K; Osawa M; Nagata S; Ishigaki K Brain Dev; 2016 Mar; 38(3):324-30. PubMed ID: 26363734 [TBL] [Abstract][Full Text] [Related]
5. A Portuguese case of Fukuyama congenital muscular dystrophy caused by a multi-exonic duplication in the fukutin gene. Costa C; Oliveira J; Gonçalves A; Santos R; Bronze-da-Rocha E; Rebelo O; Pais RP; Fineza I Neuromuscul Disord; 2013 Jul; 23(7):557-61. PubMed ID: 23582336 [TBL] [Abstract][Full Text] [Related]
6. Fukutin mutations in non-Japanese patients with congenital muscular dystrophy: less severe mutations predominate in patients with a non-Walker-Warburg phenotype. Yis U; Uyanik G; Heck PB; Smitka M; Nobel H; Ebinger F; Dirik E; Feng L; Kurul SH; Brocke K; Unalp A; Özer E; Cakmakci H; Sewry C; Cirak S; Muntoni F; Hehr U; Morris-Rosendahl DJ Neuromuscul Disord; 2011 Jan; 21(1):20-30. PubMed ID: 20961758 [TBL] [Abstract][Full Text] [Related]
7. Novel mutation in the fukutin gene in an Egyptian family with Fukuyama congenital muscular dystrophy and microcephaly. Ismail S; Schaffer AE; Rosti RO; Gleeson JG; Zaki MS Gene; 2014 Apr; 539(2):279-82. PubMed ID: 24530477 [TBL] [Abstract][Full Text] [Related]
8. The gross motor function measure is valid for Fukuyama congenital muscular dystrophy. Sato T; Adachi M; Nakamura K; Zushi M; Goto K; Murakami T; Ishiguro K; Shichiji M; Saito K; Ikai T; Osawa M; Kondo I; Nagata S; Ishigaki K Neuromuscul Disord; 2017 Jan; 27(1):45-49. PubMed ID: 27818010 [TBL] [Abstract][Full Text] [Related]
9. Epilepsy in patients with advanced Fukuyama congenital muscular dystrophy. Kuwayama R; Suzuki Y; Nishikawa M; Kimizu T; Nakajima K; Ikeda T; Mogami Y; Yanagihara K Brain Dev; 2021 Jan; 43(1):106-110. PubMed ID: 32723526 [TBL] [Abstract][Full Text] [Related]
10. [Current status and future prospects of research on Fukuyama muscular dystrophy]. Toda T Nihon Rinsho; 2015 Aug; 73(8):1425-36. PubMed ID: 26281700 [TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic analysis of a Korean patient with Fukuyama congenital muscular dystrophy. Lee J; Lee BL; Lee M; Kim JH; Kim JW; Ki CS J Neurol Sci; 2009 Jun; 281(1-2):122-4. PubMed ID: 19324374 [TBL] [Abstract][Full Text] [Related]
12. Phenotypic spectrum of Fukutinopathy: most severe phenotype of Fukutinopathy. Yoshioka M Brain Dev; 2009 Jun; 31(6):419-22. PubMed ID: 18834683 [TBL] [Abstract][Full Text] [Related]
13. Antisense oligonucleotide induced pseudoexon skipping and restoration of functional protein for Fukuyama muscular dystrophy caused by a deep-intronic variant. Enkhjargal S; Sugahara K; Khaledian B; Nagasaka M; Inagaki H; Kurahashi H; Koshimizu H; Toda T; Taniguchi-Ikeda M Hum Mol Genet; 2023 Apr; 32(8):1301-1312. PubMed ID: 36426838 [TBL] [Abstract][Full Text] [Related]
14. Cardiac involvement in Fukuyama muscular dystrophy is less severe than in Duchenne muscular dystrophy. Yamamoto T; Taniguchi-Ikeda M; Awano H; Matsumoto M; Lee T; Harada R; Imanishi T; Hayashi N; Sakai Y; Morioka I; Takeshima Y; Iijima K; Saegusa J; Toda T Brain Dev; 2017 Nov; 39(10):861-868. PubMed ID: 28578814 [TBL] [Abstract][Full Text] [Related]
15. Renal dysfunction is rare in Fukuyama congenital muscular dystrophy. Ishigaki K; Kato I; Murakami T; Sato T; Shichiji M; Ishiguro K; Ishizuka K; Funatsuka M; Saito K; Osawa M; Nagata S Brain Dev; 2019 Jan; 41(1):43-49. PubMed ID: 30077507 [TBL] [Abstract][Full Text] [Related]
16. Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy. Taniguchi-Ikeda M; Kobayashi K; Kanagawa M; Yu CC; Mori K; Oda T; Kuga A; Kurahashi H; Akman HO; DiMauro S; Kaji R; Yokota T; Takeda S; Toda T Nature; 2011 Oct; 478(7367):127-31. PubMed ID: 21979053 [TBL] [Abstract][Full Text] [Related]
17. Seizure-genotype relationship in Fukuyama-type congenital muscular dystrophy. Yoshioka M; Higuchi Y; Fujii T; Aiba H; Toda T Brain Dev; 2008 Jan; 30(1):59-67. PubMed ID: 17597323 [TBL] [Abstract][Full Text] [Related]
18. A rapid diagnostic method for a retrotransposal insertional mutation into the FCMD gene in Japanese patients with Fukuyama congenital muscular dystrophy. Kato R; Kawamura J; Sugawara H; Niikawa N; Matsumoto N Am J Med Genet A; 2004 May; 127A(1):54-57. PubMed ID: 15103718 [TBL] [Abstract][Full Text] [Related]
19. Severe muscle damage following viral infection in patients with Fukuyama congenital muscular dystrophy. Murakami T; Ishigaki K; Shirakawa S; Ikenaka H; Sakauchi M; Osawa M Brain Dev; 2012 Apr; 34(4):293-7. PubMed ID: 21726969 [TBL] [Abstract][Full Text] [Related]
20. Fukutin gene retrotransposal insertion in a non-Japanese Fukuyama congenital muscular dystrophy (FCMD) patient. Xiong H; Wang S; Kobayashi K; Jiang Y; Wang J; Chang X; Yuan Y; Liu J; Toda T; Fukuyama Y; Wu X Am J Med Genet A; 2009 Nov; 149A(11):2403-8. PubMed ID: 19842201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]